Constitutive activation of NF-κB inhibits terminal differentiation of myogenic cells in response to inflammatory cytokines and in genetic muscle disorders such as muscular dystrophy15, 16. This evidence concerns the gene NFKB1 and hereditary skeletal muscle disorder.